What is the address of DR. KLAARTJE LOWETTE, inwendige geneeskunde?

The registered office of DR. KLAARTJE LOWETTE, inwendige geneeskunde is located at Loonderweg 3, 3840 Tongeren-Borgloon.

Is DR. KLAARTJE LOWETTE, inwendige geneeskunde still active?

Yes. According to the CBE (17 September 2026) DR. KLAARTJE LOWETTE, inwendige geneeskunde is active, legal situation “Normale toestand”, started on 26 November 2015.

Is DR. KLAARTJE LOWETTE, inwendige geneeskunde registered on Peppol?

Yes, DR. KLAARTJE LOWETTE, inwendige geneeskunde is registered on the Peppol network with ID 0208:0643655277.

What is the enterprise number of DR. KLAARTJE LOWETTE, inwendige geneeskunde?

The enterprise number of DR. KLAARTJE LOWETTE, inwendige geneeskunde is BE0643655277.

When was DR. KLAARTJE LOWETTE, inwendige geneeskunde founded?

DR. KLAARTJE LOWETTE, inwendige geneeskunde was founded on 26 November 2015.

Who are the directors of DR. KLAARTJE LOWETTE, inwendige geneeskunde?

According to the 2025 annual accounts, the directors of DR. KLAARTJE LOWETTE, inwendige geneeskunde are: KLAARTJE LOWETTE.

Is DR. KLAARTJE LOWETTE, inwendige geneeskunde a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 November 2015; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. KLAARTJE LOWETTE, inwendige geneeskunde make in 2025?

DR. KLAARTJE LOWETTE, inwendige geneeskunde posted a profit after taxes of € 178,592 in financial year 2025.

What is the revenue of DR. KLAARTJE LOWETTE, inwendige geneeskunde?

As a small company, DR. KLAARTJE LOWETTE, inwendige geneeskunde is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 245,586.

DR. KLAARTJE LOWETTE, inwendige geneeskunde (Private Limited)

Dossier DR. KLAARTJE LOWETTE, inwendige geneeskunde, printed on 17 September 2026 from databakkes.be/en/0643655277/dr-klaartje-lowette-inwendige-geneeskunde. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. KLAARTJE LOWETTE, inwendige geneeskunde from Tongeren-Borgloon, company number BE0643655277, closed financial year 2025 with a result of € 178,592 after tax. For that financial year DR. KLAARTJE LOWETTE, inwendige geneeskunde recorded a gross margin of € 245,586 and equity of € 198,086. Compared with financial year 2024, the result moved from € 124,150 to € 178,592. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 24, 2026.

What it is worth Growing

€ 198,086

▲ 38% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 178,592

▲ 44% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 299,481

▲ 18% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 124,000 paid out

69 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 13,763

▼ 20% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 162,345

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 1,022

▲ € 808 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 8,993

▲ 100% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 131,738 Gross margin 2022: € 131,738 First fiscal year in the series	€ 403,143 Gross margin 2023: € 403,143 ▲ 206% vs 2022 (€ 131,738) Favourable step	€ 171,827 Gross margin 2024: € 171,827 ▼ 57% vs 2023 (€ 403,143) Unfavourable step	€ 245,586 Gross margin 2025: € 245,586 ▲ 43% vs 2024 (€ 171,827) Favourable step	▲ 43%
Profit after taxes	€ 97,350 Profit after taxes 2022: € 97,350 First fiscal year in the series	€ 301,508 Profit after taxes 2023: € 301,508 ▲ 210% vs 2022 (€ 97,350) Favourable step	€ 124,150 Profit after taxes 2024: € 124,150 ▼ 59% vs 2023 (€ 301,508) Unfavourable step	€ 178,592 Profit after taxes 2025: € 178,592 ▲ 44% vs 2024 (€ 124,150) Favourable step	▲ 44%
Equity	€ 87,835 Equity 2022: € 87,835 First fiscal year in the series	€ 269,343 Equity 2023: € 269,343 ▲ 207% vs 2022 (€ 87,835) Favourable step	€ 143,494 Equity 2024: € 143,494 ▼ 47% vs 2023 (€ 269,343) Unfavourable step	€ 198,086 Equity 2025: € 198,086 ▲ 38% vs 2024 (€ 143,494) Favourable step	▲ 38%
Total debts	€ 138,913 Total debts 2022: € 138,913 First fiscal year in the series	€ 158,472 Total debts 2023: € 158,472 ▲ 14% vs 2022 (€ 138,913) Unfavourable step	€ 260,851 Total debts 2024: € 260,851 ▲ 65% vs 2023 (€ 158,472) Unfavourable step	€ 496,370 Total debts 2025: € 496,370 ▲ 90% vs 2024 (€ 260,851) Unfavourable step	▲ 90%
Cash	€ 200,268 Cash 2022: € 200,268 First fiscal year in the series	€ 276,930 Cash 2023: € 276,930 ▲ 38% vs 2022 (€ 200,268) Favourable step	€ 252,871 Cash 2024: € 252,871 ▼ 9% vs 2023 (€ 276,930) Unfavourable step	€ 299,481 Cash 2025: € 299,481 ▲ 18% vs 2024 (€ 252,871) Favourable step	▲ 18%
Land & buildings	€ 7,966 Land & buildings 2022: € 7,966 First fiscal year in the series	€ 5,865 Land & buildings 2023: € 5,865 ▼ 26% vs 2022 (€ 7,966) Unchanged	€ 17,088 Land & buildings 2024: € 17,088 ▲ 191% vs 2023 (€ 5,865) Unchanged	€ 83,296 Land & buildings 2025: € 83,296 ▲ € 66,207 vs 2024 (€ 17,088) Unchanged	▲ € 66,207
Retained profit	€ 69,235 Retained profit 2022: € 69,235 First fiscal year in the series	€ 250,743 Retained profit 2023: € 250,743 ▲ 262% vs 2022 (€ 69,235) Favourable step	€ 124,894 Retained profit 2024: € 124,894 ▼ 50% vs 2023 (€ 250,743) Unfavourable step	€ 179,486 Retained profit 2025: € 179,486 ▲ 44% vs 2024 (€ 124,894) Favourable step	▲ 44%
Dividend	€ 100,000 Dividend 2022: € 100,000 First fiscal year in the series	€ 120,000 Dividend 2023: € 120,000 ▲ 20% vs 2022 (€ 100,000) Unchanged	€ 250,000 Dividend 2024: € 250,000 ▲ 108% vs 2023 (€ 120,000) Unchanged	€ 124,000 Dividend 2025: € 124,000 ▼ 50% vs 2024 (€ 250,000) Unchanged	▼ 50%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 162,345 Bank debt 2025: € 162,345 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 226,748 Balance sheet total 2022: € 226,748 First fiscal year in the series	€ 427,815 Balance sheet total 2023: € 427,815 ▲ 89% vs 2022 (€ 226,748) Unchanged	€ 404,345 Balance sheet total 2024: € 404,345 ▼ 5% vs 2023 (€ 427,815) Unchanged	€ 694,455 Balance sheet total 2025: € 694,455 ▲ 72% vs 2024 (€ 404,345) Unchanged	▲ 72%

Key figures of DR. KLAARTJE LOWETTE, inwendige geneeskunde, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. KLAARTJE LOWETTE, inwendige geneeskunde?

What happened at DR. KLAARTJE LOWETTE, inwendige geneeskunde in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 24, 2026 New annual accounts for financial year 2025: profit of € 178,592 (▲ 44% vs 2024). Source: NBB ↗
Nov 26, 2015 New establishment in Tongeren-Borgloon. KBO
2015 KLAARTJE LOWETTE became a director. NBB
Nov 26, 2015 Start of the company according to the CBE. KBO

In short

From € 97,350 profit in 2022 to € 178,592 profit in 2025.

Paid € 214,044 in corporate taxes since 2022.

Best year ever: 2023, with € 301,508 profit.

Paid out € 594,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. KLAARTJE LOWETTE, inwendige geneeskunde? We notify you, reason included.

Follow DR. KLAARTJE LOWETTE, inwendige geneeskunde

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit